Skip to main content

Series A Biotechnology Companies

Explore 772 biotechnology startups that raised series a funding. Access verified founder contact information and fundraising data.

Total Companies
772
Total Funding
$762.6M
Avg Funding
$30.5M
Cities
21

Export 772 Series A Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
San Diego, United States
$28.0M
raised

Function Oncology is a precision medicine company advancing a CRISPR-powered personalized functional genomics platform.

Apr 2023
Series A

Founder Contacts

30,000+ verified contacts

Abertillery, United Kingdom
$12.0M
raised

Mootral is an AgriTech company focused on tackling two of the world's biggest crises: climate change and antimicrobial resistance (AMR).

Apr 2022
Series A

Founder Contacts

30,000+ verified contacts

Woburn, United States
$54.0M
raised

Vivatides Therapeutics develops RNA treatments to help improve patients' lives using biotechnology research.

Apr 2026
Series A

Founder Contacts

30,000+ verified contacts

Mountain View, United States

Metanovas develops drugs, dietary supplements, functional foods, and cosmetics using AI technology.

Mar 2026
Series A

Founder Contacts

30,000+ verified contacts

South San Francisco, United States
$19.0M
raised

Tacit Therapeutics created RNA-targeting treatments for devastating diseases.

Mar 2026
Series A

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 772 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Amsterdam, The Netherlands
$31.0M
raised

Scenic Biotech is a developer of a genomics and immunotherapy technologies created to unlock genetic suppressors.

Mar 2022
Series A

Founder Contacts

30,000+ verified contacts

New York, United States
$6.1M
raised

OccamzRazor is a combines machine learning and first-in-class biological techniques to improve outcomes in drug discovery and development.

Mar 2022
Series A

Founder Contacts

30,000+ verified contacts

Boston, United States
$7.0M
raised

Mytide Therapeutics is committed to providing peptides to serve a diverse array of applications.

Mar 2022
Series A

Founder Contacts

30,000+ verified contacts

San Diego, United States
$40.0M
raised

Reinventing drug development from the ground up to make safe, effective oligonucleotide-based medicines possible on demand.

Mar 2022
Series A

Founder Contacts

30,000+ verified contacts

Newton, United States
$82.5M
raised

Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering.

Mar 2022
Series A

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 772 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Durham, United States
$4.1M
raised

Mentara Bio develops neurocircuit-targeting therapies and conducts clinical research for neurological disorders such as epilepsy.

Mar 2023
Series A

Founder Contacts

30,000+ verified contacts

Cologne, Germany
$4.1M
raised

Cellbox Solutions is a young technology company that focuses on innovative logistic solutions for the global BioMed industry.

Mar 2026
Series A

Founder Contacts

30,000+ verified contacts

London, United Kingdom
$15.0M
raised

Shellworks is a biomaterials company that develops and manufactures materials that offers alternative to conventional plastics.

Mar 2026
Series A

Founder Contacts

30,000+ verified contacts

Cardiff, United Kingdom
$9.3M
raised

Antiverse is dedicated to engineering the future of drug development to change the course of people's lives.

Mar 2026
Series A

Founder Contacts

30,000+ verified contacts

New York, United States
$50.0M
raised

Prolium is a biotechnology company, which specializes in providing breakthrough therapies to the patients with autoimmune diseases.

Mar 2026
Series A

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 772 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Burlingame, United States
$21.3M
raised

Apeximmune Therapeutics engages in the discovery and development of novel biologics that modulate the immune system.

Mar 2025
Series A

Founder Contacts

30,000+ verified contacts

Gaithersburg, United States
$27.0M
raised

RNAimmune is a biopharmaceutical company specializing in the discovery and development of mRNA-based therapeutics and vaccines.

Mar 2022
Series A

Founder Contacts

30,000+ verified contacts

Boston, United States
$67.0M
raised

Hillstar Bio is developing precision immunotherapies to treat autoimmune diseases.

Mar 2025
Series A

Founder Contacts

30,000+ verified contacts

Brookline, United States
$20.0M
raised

Edgewood Oncology is promoting a first-in-class therapy for malignancies that are challenging to treat.

Mar 2024
Series A

Founder Contacts

30,000+ verified contacts

Cambridge, United Kingdom
$87.1M
raised

Immutrin is a biotech developing next‑generation antibody therapies to clear amyloid deposits and reverse amyloidosis.

Mar 2026
Series A

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 772 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Bozeman, United States

ALERCELL AI-powered epigenetic diagnostic platform detecting leukemia up to 41 months before clinical symptoms.

Mar 2026
Series A

Founder Contacts

30,000+ verified contacts

Orange, Australia
$13.3M
raised

Cauldron Ferm is a bio-acceleration process that exponentially scales up any precision fermented prototype to commercial quantities.

Mar 2026
Series A

Founder Contacts

30,000+ verified contacts

New York, United States
$60.0M
raised

Gilgamesh Pharmaceuticals is a clinical-stage biotechnology company that develops psychedelic and related drugs to treat mental illnesses.

Mar 2026
Series A

Founder Contacts

30,000+ verified contacts

Leuven, Belgium
$83.9M
raised

Augustine Therapeutics is discovering and developing innovative medicines for the treatment of neuromuscular and neurodegeneratives diseases

Mar 2025
Series A

Founder Contacts

30,000+ verified contacts

Belmont, United States
$21.0M
raised

Oryon Cell treatments is a clinical-stage biotechnology business exploring autologous cell treatments for neurodegenerative illnesses.

Mar 2026
Series A

Founder Contacts

30,000+ verified contacts

Showing 226 to 250 of 772 companies

Ready to Connect with Series A Biotechnology Startups?

Get verified founder emails, funding details, and company data for 772 series a biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked